| dc.creator |
PIHTILI, Aylin; İSTANBUL ÜNİVERSİTESİ, İSTANBUL TIP FAKÜLTESİ |
|
| dc.creator |
MAMMADOVA, Konul; İSTANBUL ÜNİVERSİTESİ, İSTANBUL TIP FAKÜLTESİ |
|
| dc.creator |
KIYAN, Esen; İSTANBUL ÜNİVERSİTESİ, İSTANBUL TIP FAKÜLTESİ |
|
| dc.date |
2021-09-13T00:00:00Z |
|
| dc.date.accessioned |
2021-12-03T11:47:03Z |
|
| dc.date.available |
2021-12-03T11:47:03Z |
|
| dc.identifier |
https://dergipark.org.tr/tr/pub/sdutfd/issue/64881/822908 |
|
| dc.identifier |
10.17343/sdutfd.822908 |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/94248 |
|
| dc.description |
ObjectiveLactate level is an indicator of tissue oxygenation.It might be valuable for COPD patients to havea prognostic marker. Thus, we aimed to evaluatethe relationship between lactate level and COPDclassification, FEV1 level, exacerbations, hypoxemiain stable COPD patients.Materials and MethodsIn this retrospective study, demographics, arterialblood gas analysis, exacerbation history, GOLDclassification, pulmonary function tests, long-termoxygen therapy (LTOT) and non-invasive mechanicalventilation (NIMV) usage in stable COPD patientswere recorded.ResultsTotally 103 patients (M / F: 90/13, mean age: 66.8 ±8.0years) were included. Mean FEV1:45±20%, FVC:63±22%, PaO2:66±15mmHg, PaCO2:43±8mmHg,lactate level: 1.5±0.6mmol/L. The groups of thepatients according to GOLD COPD classification wereas follows;; 11.7%, 15.5%, 24.3%, 48.5% in A,B,C,D,respectively. Of patients 47.6% were using LTOT and37.3% were using NIMV. Lactate level of the patientsin category D was significantly higher than the patientsin A, B, C categories (p |
|
| dc.description |
AmaçMorbidite ve mortalitesi yüksek olan KOAH’da, prognostikbelirteçlerin saptanması önemlidir. Plazma laktatdüzeyi, doku oksijen ihtiyacını gösteren ve kolayulaşılabilen bir tetkiktir. Çalışmamızın amacı; stabilKOAH olgularında plazma laktat düzeyi ile GOLDKOAH kategorisi, FEV1, ataklar ve hipoksemi arasındakiilişkiyi incelemektir.Gereç ve YöntemGöğüs Hastalıkları Polikliniği’ne başvuran stabil dönemdekiKOAH olguları retrospektif olarak değerlendirildi.Demografik özellikler, arter kan gazı analizleri,yıllık atak sayıları, GOLD KOAH kategorisine göre;A,B,C,D sınıfları, spirometrik parametreler, evde uzunsüreli oksijen tedavisi (USOT) ve non-invaziv mekanikventilasyon (NİMV) kullanıp kullanmadıkları kaydedildi.BulgularToplam 103 stabil KOAH olgusu (E/K: 90/13, ortalamayaş: 66.8±8.0/yıl) çalışmaya dahil edildi. OlgularınFEV1:%45.7±20.2, FVC:%63.5±22.2, Pa-O2:66.3±15.0mmHg, PaCO2:43.9±8.3mmHg, laktat:1.5±0.6 mmol/L idi. On iki olgu(%11.7) A, 16 olgu(%15.5) B, 25 olgu (%24.3) C, 50 olgu (%48.5) D grubundaidi. Olguların %47.6’sı (n=49) USOT, %37.3’ü(n=28) NİMV kullanmakta idi. D kategorisindeki olgulardalaktat düzeyi A, B, C sınıflarına göre belirginyüksekti (p |
|
| dc.format |
application/pdf |
|
| dc.language |
tr |
|
| dc.publisher |
Süleyman Demirel Üniversitesi |
|
| dc.publisher |
Süleyman Demirel University |
|
| dc.relation |
https://dergipark.org.tr/tr/download/article-file/1385947 |
|
| dc.source |
Volume: 28, Issue: 3
427-432 |
en-US |
| dc.source |
1300-7416 |
|
| dc.source |
2602-2109 |
|
| dc.source |
SDÜ Tıp Fakültesi Dergisi |
|
| dc.subject |
GOLD,COPD,lactate level |
|
| dc.subject |
GOLD,KOAH,laktat düzeyi |
|
| dc.title |
LACTATE LEVEL IN STABLE COPD PATIENTS |
en-US |
| dc.title |
STABİL KOAH OLGULARINDA PLAZMA LAKTAT DÜZEYİ |
tr-TR |
| dc.type |
info:eu-repo/semantics/article |
|
| dc.citation |
Referans 1: Neumeier A, Keith R. Clinical Guideline Highlights for the Hospitalist: The GOLD and NICE Guidelines for the Management of COPD. J Hosp Med. 2020;15(4):240-41. |
|
| dc.citation |
Referans 2: Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2020. Available from: http://www.goldcopd.org/ |
|
| dc.citation |
Referans 3:Jansen TC, van Bommel J, Bakker J. Blood lactate monitoring in critically ill patients: a systematic health technology assessment. Crit Care Med. 2009; 37(10):2827–39 |
|
| dc.citation |
Referans 4: Crawford SO, Ambrose MS, Hoogeveen RC, Brancati FL, Ballantyne CM, Young JH. Association of lactate with blood pressure before and after rapid weight loss. Am J Hypertens. 2008; 21(12):1337–42. |
|
| dc.citation |
Referans 5: Zagari F, Jordan M, Stettler M, Zagari F, Jordan M, Stettler M, Broly H, Wurm FM. Lactate metabolism shift in CHO cell culture: the role of mitochondrial oxidative activity. N Biotechnol. 2013; 30(2):238–45. |
|
| dc.citation |
Referans 6:Shapiro NI, Trzeciak S, Hollander JE, Birkhahn R, Otero R, Osborn TM, et al. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med. 2009; 37(1):96-104 |
|
| dc.citation |
Referans 7:Vincent JL, Quintairos E Silva A, Couto Jr L, Taccone FS. The value of blood lactate kinetics in critically ill patients: a systematic review. Crit Care 2016; 20(1):257. |
|
| dc.citation |
Referans 8: Zhang Z, Xu X. Lactate clearance is a useful biomarker for the prediction of all-cause mortality in critically ill patients: a systematic review and meta-analysis. Crit Care Med 2014; 42(9):2118–25. |
|
| dc.citation |
Referans 9: Haas SA, Lange T, Saugel B, Petzoldt M, Fuhrmann V, Metschke M, et al. Severe hyperlactatemia, lactate clearance and mortality in unselected critically ill patients. Intensive Care Med. 2016; 42(2):202–10 |
|
| dc.citation |
Referans 10: Galić K, Pravdić D, Prskalo Z, Kukulj S, Starčević B, Vukojević M. Prognostic value of lactates in relation to gas analysis and acid-base status in patients with pulmonary embolism. Croat Med J. 2018; 59(4):149-55. |
|
| dc.citation |
Referans 11: Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin A, Ressler JA, et al.Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004; 32(8):1637-42 |
|
| dc.citation |
Referans 12: Nichol AD, Egi M, Pettila V, Bellomo R, French C, Hart G, et al. Relative hyperlactatemia and hospital mortality in critically ill patients: a retrospective multi-centre study. Crit Care 2010; 14(1):25. |
|
| dc.citation |
Referans 13: Durmuş U, Doğan NÖ, Pekdemir M, Yılmaz S, Yaka E, Karadaş A, et al.The value of lactate clearance in admission decisions of patients with acute exacerbation of COPD. Am J Emerg Med. 2018 ; 36(6):972-76 |
|
| dc.citation |
Referans 14:Brasil Santos D, de Assis Viegas CA. Correlation of levels of obstruction in COPD with lactate and six-minute walk test. Rev Port Pneumol. 2009; 15(1):11-25. |
|
| dc.citation |
Referans 15:Tanaka Y, Hino M, Morikawa T, Takeuchi K, Mizuno K, Kudoh S. Arterial blood lactate is a useful guide to when rehabilitation should be instigated in COPD. Respirology. 2008; 13(4):564-8. |
|
| dc.citation |
Referans 16:Skjørten I, Hilde JM, Melsom MN, Hisdal J, Hansteen V, Steine K, et al. Exercise capacity in COPD patients with exercise-induced pulmonary hypertension. Int J Chron Obstruct Pulmon Dis. 2018; 13:3599-610. |
|
| dc.citation |
Referans 17:Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yemault JC. Lung volumes and forced ventilatory flows.Report working party standardization of lung function tests, European community for steel and coal.Official statement of the European respiratory society. Eur Respir J Suppl. 1993; 16:5–40 |
|